The preoperative and postoperative values of urinary pseudouridine:creatinine (phi:C) and beta-aminoisobutyric acid:creatinine (beta AIB:C) were estimated, in 192 patients with urothelial tumours of the bladder, 92 of whom had not previously been diagnosed. Urinary phi:C ratio correlated with the grade of tumour cell dysplasia (being highest in dysplasia grade 3), and to a lesser extent with the clinical stage. The treatment had no major influence on the excretion ratios. Decreased ratios, or those within the reference range, were associated with a better prognosis than increased ratios, and if both were increased at the same time the risk for progression of the disease was high. The biological tumour markers pseudouridine and beta-aminoisobutyric acid may be helpful in the diagnosis of tumours in the upper urinary tract, and in the follow-up of patients with tumours of the bladder.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/00365599309180413 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.
Int J Obes (Lond)
July 2015
1] Liver Research Unit, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy [2] Hepato-Metabolic Disease Unit, 'Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
Background: Nowadays, non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases in children. Our recent clinical trial demonstrated that dietary and VSL#3-based interventions may improve fatty liver by ultrasound and body mass index (BMI) after 4 months.
Objectives: As in this short-term trial, as in others, it is impracticable to monitor response to therapy or treatment by liver biopsy, we aimed to identify a panel of potential non-invasive metabolic biomarkers by a urinary metabolic profiling.
Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder.
Scand J Urol Nephrol
June 1993
Laboratory of Chromatography, Sundby Hospital, Roskilde, Denmark.
The preoperative and postoperative values of urinary pseudouridine:creatinine (phi:C) and beta-aminoisobutyric acid:creatinine (beta AIB:C) were estimated, in 192 patients with urothelial tumours of the bladder, 92 of whom had not previously been diagnosed. Urinary phi:C ratio correlated with the grade of tumour cell dysplasia (being highest in dysplasia grade 3), and to a lesser extent with the clinical stage. The treatment had no major influence on the excretion ratios.
View Article and Find Full Text PDFExcretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Scand J Urol Nephrol
February 1991
Laboratory of Chromatography, Sundby Hospital, Copenhagen, Denmark.
In 39 patients with either pelvic or renal cell tumours, the pre-operative urinary excretion ratios of pseudouridine/creatinine (psi:C) and beta-aminoisobutyric acid/creatinine (BAIB:C) were estimated. In 34/39 of the patients (87%), including both types of tumours, psi: C was found to be increased, and in only one patient was the value decreased. Twenty-five of the patients (64%) had a BAIB:C ratio within the normal range.
View Article and Find Full Text PDFPseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Scand J Urol Nephrol
February 1991
Laboratory of Chromatography, Sundby Hospital, Copenhagen, Denmark.
The sex- and age-related urinary excretion of pseudouridine/creatinine and beta-aminoisobutyric acid/creatinine was studied in 77 healthy subjects (24 children and 53 adults, 27 of whom were women). The highest values were found in the youngest children. We compared the excretion ratios of pseudouridine/creatinine and beta-aminoisobutyric acid/creatinine in women and men and found no significant differences between them.
View Article and Find Full Text PDFbeta-Aminoisobutyric acid as a marker of thymine catabolism in malignancy.
Clin Chim Acta
June 1987
Children's Hospital Het Emma Kinderziekenhuis, Amsterdam, The Netherlands.
Urine from untreated patients with various tumours and controls has been examined for the excretion of beta-aminoisobutyric acid and uric acid. The patients were classified into four groups: I, beta-aminoisobutyric acid and uric acid both normal; II, beta-aminoisobutyric acid normal, uric acid elevated; III, beta-aminoisobutyric acid elevated, uric acid normal; IV, beta-aminoisobutyric acid and uric acid both elevated. Uric acid was used as an indicator for tissue-breakdown.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!